Evaluation of a commercial recombinant tissue-type plasminogen activator preparation in the subretinal space of the cat.
about
Increased retinal toxicity of intravitreal tissue plasminogen activator in a central retinal vein occlusion model.Tissue plasminogen activator in the treatment of vitreoretinal diseases.Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator.Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular DegenerationRecombinant tissue plasminogen activator injected into the vitreous cavity may penetrate the retinal veins of a porcine model of vascular occlusion.Retinal sensitivity after displacement of submacular hemorrhage due to polypoidal choroidal vasculopathy: effectiveness and safety of subretinal tissue plasminogen activator.
P2860
Evaluation of a commercial recombinant tissue-type plasminogen activator preparation in the subretinal space of the cat.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Evaluation of a commercial rec ...... e subretinal space of the cat.
@en
Evaluation of a commercial rec ...... e subretinal space of the cat.
@nl
type
label
Evaluation of a commercial rec ...... e subretinal space of the cat.
@en
Evaluation of a commercial rec ...... e subretinal space of the cat.
@nl
prefLabel
Evaluation of a commercial rec ...... e subretinal space of the cat.
@en
Evaluation of a commercial rec ...... e subretinal space of the cat.
@nl
P2093
P1433
P1476
Evaluation of a commercial rec ...... e subretinal space of the cat.
@en
P2093
J D Benner
L M Hjelmeland
M B Landers
P304
P356
10.1001/ARCHOPHT.1991.01080120115039
P407
P577
1991-12-01T00:00:00Z